Intraoperative Radiation Therapy Market Size, Share & Analysis Report, 2021-2027
The global Intraoperative Radiation Therapy market gathered revenue around USD 47 million in 2020 and market is set to grow USD 70 million by the end of 2027 and is estimated to expand at a modest CAGR of 5.9% during the prediction period 2021 to 2027.
Growth Factors:
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications are expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Intraoperative Radiation Therapy market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Intraoperative Radiation Therapy market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 70 Million by 2027 |
| Growth Rate | CAGR of 5.9% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Product and Service, Technology, Application, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | ZEISS Group , iCAD, Inc. , Eckert & Ziegler , Elekta AB , GMV Innovating Solutions , Sensus Healthcare, Inc. , IntraOp Medical, Inc., Isoray, Inc. , Becton, Dickinson and Company , Sordina IORT Technologies , Varian Medical Systems, Inc. , SeeDos Ltd., IsoAid LLC , Ariane Medical Systems Ltd. , Panacea Medical Technologies Pvt. Ltd. , Salutaris Medical Devices , Brainlab AG among others |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Intraoperative Radiation Therapy market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is expected to command the largest share of the Intraoperative radiation therapy market in 2019
North America, comprising the US and Canada, accounted major share of the intraoperative radiation therapy market in 2019. The major factors driving market growth in this region are the easy availability and high adoption of IORT for cancer treatment, the rising incidence of cancer, and significant per capita annual healthcare expenditure in the US and Canada. Furthermore, associations such as the American Society for Radiation Oncology (ASTRO) have advocated the use of low-energy IORT, which has contributed to its increased adoption in North America..
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Intraoperative Radiation Therapy Market are: ZEISS Group , iCAD, Inc. , Eckert & Ziegler , Elekta AB , GMV Innovating Solutions , Sensus Healthcare, Inc. , IntraOp Medical, Inc., Isoray, Inc. , Becton, Dickinson and Company , Sordina IORT Technologies , Varian Medical Systems, Inc. , SeeDos Ltd., IsoAid LLC , Ariane Medical Systems Ltd. , Panacea Medical Technologies Pvt. Ltd. , Salutaris Medical Devices , Brainlab AG among others
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Intraoperative radiation therapy Market, by Product and Service
Global Intraoperative radiation therapy Market, by Technology
Global Intraoperative radiation therapy Market, by Application
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Intraoperative Radiation Therapy Market, By Product and Service
7.1. Intraoperative Radiation Therapy Market, by Product and Service, 2021-2027
7.1.1. Products
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Systems/Accelerators
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Applicators & Afterloaders
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Treatment Planning Systems
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Accessories
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Services
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Intraoperative Radiation Therapy Market, By Technology
8.1. Intraoperative Radiation Therapy Market, by Technology, 2021-2027
8.1.1. Electron IORT
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Intraoperative Brachytherapy
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Intraoperative Radiation Therapy Market, By Application
9.1. Intraoperative Radiation Therapy Market, by Application, 2021-2027
9.1.1. Breast Cancer
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Breast Cancer
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Gastrointestinal Cancer
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Head & Neck Cancer
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Colorectal Cancer
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Endometrial & Cervical Cancer
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Lung Cancer
9.1.7.1. Market Revenue and Forecast (2016-2027)
9.1.8. Other Cancers (penile cancer and prostate cancer)
9.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Intraoperative Radiation Therapy Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.1.2. Market Revenue and Forecast, by Technology (2016-2027)
10.1.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.2.2. Market Revenue and Forecast, by Technology (2016-2027)
10.2.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.3.2. Market Revenue and Forecast, by Technology (2016-2027)
10.3.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product and Service (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Application (2016-2027)
Chapter 11. Company Profiles
11.1. ZEISS Group (Germany)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. iCAD, Inc. (US)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Eckert & Ziegler (Germany)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Elekta AB (Sweden)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. GMV Innovating Solutions (Spain)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Sensus Healthcare, Inc. (US)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. IntraOp Medical, Inc. (US)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Isoray, Inc. (US)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Becton, Dickinson and Company (US)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Sordina IORT Technologies (Italy)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Varian Medical Systems, Inc. (US)
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. SeeDos Ltd. (UK)
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. IsoAid LLC (US)
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Ariane Medical Systems Ltd. (UK)
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Panacea Medical Technologies Pvt. Ltd. (India)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. Salutaris Medical Devices (US)
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
11.17. Brainlab AG (Germany)
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives
11.18. RaySearch Laboratories (Sweden)
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives
11.19. REMEDI Co., Ltd. (South Korea)
11.19.1. Company Overview
11.19.2. Product Offerings
11.19.3. Financial Performance
11.19.4. Recent Initiatives
11.20. Merit Medical Systems Inc. (US)
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance
11.20.4. Recent Initiatives
11.21. Xstrahl Medical (UK)
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives
11.22. DOSIsoft SA (France)
11.22.1. Company Overview
11.22.2. Product Offerings
11.22.3. Financial Performance
11.22.4. Recent Initiatives
11.23. Huiheng Medical (China)
11.23.1. Company Overview
11.23.2. Product Offerings
11.23.3. Financial Performance
11.23.4. Recent Initiatives
11.24. Sun Nuclear Corporation (US)
11.24.1. Company Overview
11.24.2. Product Offerings
11.24.3. Financial Performance
11.24.4. Recent Initiatives
11.25. Theragenics Corporation (US)
11.25.1. Company Overview
11.25.2. Product Offerings
11.25.3. Financial Performance
11.25.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers